Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.

MLA

Kasahara, A., et al. “Risk Factors for Hepatocellular Carcinoma and Its Incidence after Interferon Treatment in Patients with Chronic Hepatitis C. Osaka Liver Disease Study Group.” Hepatology (Baltimore, Md.), vol. 27, no. 5, May 1998, pp. 1394–402. EBSCOhost, https://doi.org/10.1002/hep.510270529.

APA

Kasahara, A., Hayashi, N., Mochizuki, K., Takayanagi, M., Yoshioka, K., Kakumu, S., Iijima, A., Urushihara, A., Kiyosawa, K., Okuda, M., Hino, K., & Okita, K. (1998). Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology (Baltimore, Md.), 27(5), 1394–1402. https://doi.org/10.1002/hep.510270529

Chicago

Kasahara, A, N Hayashi, K Mochizuki, M Takayanagi, K Yoshioka, S Kakumu, A Iijima, et al. 1998. “Risk Factors for Hepatocellular Carcinoma and Its Incidence after Interferon Treatment in Patients with Chronic Hepatitis C. Osaka Liver Disease Study Group.” Hepatology (Baltimore, Md.) 27 (5): 1394–1402. doi:10.1002/hep.510270529.